Twelve known triterpenoids (1-12) and two steroids (13 and 14) have been isolated from the spike of the plant Prunella vulgaris. Among them, 2α,3α,23trihydroxyursa-12,20(30)-dien-28-oic acid (10) was isolated for the first time from this plant. All isolates were evaluated for their inhibitory effect on the gene expression of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), and release of histamine in human mast cells. β-Amyrin (5), 10, and euscaphic acid (12) showed suppression of histamine release with percentage inhibitions of 46.7, 57.9, and 54.2%, respectively. In addition, 5 and 10 showed strong inhibition of TNF-α and IL-6 in the test for pro-inflammatory cytokines. Our results suggest that compounds 5 and 10 largely contribute to the anti-allergic inflammatory effect of P. vulgaris.
Prunella vulgaris L. (Labiatae) is widely distributed in Asia and
Europe [1a] . The spikes of this plant are traditionally used to treat diabetes, hypertension, acute infectious hepatitis, jaundice, and inflammation [1b] . P. vulgaris, better known as "self-heal," is used in the form of a hot water infusion sweetened with honey to treat mouth and throat sores in western herbal medicine [1c] . Studies have shown that the extract and fractions of P. vulgaris have various pharmacological properties including anticancer, antiviral, antiinflammatory, and antibiotic effects [1d] . Phytochemical studies of this medicinal plant have shown that it contains various triterpenes [1a] , flavonoids [1b], polysaccharides [1c], and saponins [1d] .
Ethanol extracts of P. vulgaris inhibited lipopolysaccharide (LPS)induced prostaglandin E2 (PGE2) and NO production in RAW 264.7 mouse macrophage cells [2a] . Because this medicinal herb has strong anti-inflammatory activity, we expect that it may inhibit the release of histamine. In our previous study, a water extract of P. vulgaris inhibited systemic anaphylaxis in a dose-dependent manner. It also inhibited serum histamine release in mice, and decreased the IgE-mediated local allergic reaction causing passive cutaneous anaphylaxis [2b]. We have used bioactive-guided fractionation to isolate compounds from this plant in order to test this theory. In this paper, we describe the isolation and elucidation of compounds (1-14) from the spikes of P. vulgaris and their activity on human mast cells. Twelve triterpenes and two steroids were purified by silica gel column chromatography and preparative HPLC. The structures of all the compounds (1-14) were elucidated by spectroscopy, including 1D and 2D NMR spectroscopy. The isolates were determined to be squalene (1) [3a] , ursolic acid (2) [3b], pyogenic acid A (3) [3c], maslinic acid (4) [3d], β-amyrin (5) [3e], 2α,3α-dihydroxyursa-12,20(30)-dien-28-oate (6) [3f], 3-epimaslinic acid (7) [3f], hederagenin (8) [3g], tormentic acid (9) [3h], 2α,3α,23-trihydroxyursa-12,20(30)-dien-28-oic acid (10) [3i], 2α,3α,24-trihydroxyursa-12,20(30)-dien-28-oic acid (11), euscaphic acid (12) [3j], spinasterone (13) [3k], and 5-stigmasta-7,22-dien-3ol (14) [3l]. This was the first time compound 10 was isolated from this plant. These isolates were evaluated for their inhibitory effect on the gene expression of the pro-inflammatory cytokines TNF-α and IL-6, and release of histamine in human mast cells ( Figure 1 ). Compounds 5, 10, and 12 inhibited histamine release with percentage inhibitions of 46.7, 57.9, and 54.2%, respectively, at a concentration of 10 μM. In the histamine release test, the 3α-form of the ursane-type triterpenoids (10 and 12) showed stronger activity than did the 3β-form, and also more hydroxyl groups are better than less. The 28-methyl group of the olean-type triterpene (5) determined this activity rather than the 28-carboxyl group in the other olean-type triterpenes (4, 7, and 8) . In addition, 5 and 10 showed strong inhibition of TNF-α and IL-6 in the test for pro-inflammatory cytokines. In conclusion, our results suggest that the triterpene constituents (5 and 10) may be responsible for the anti-allergic inflammatory effect of P. vulgaris. 
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Extraction and isolation:
The dried spikes of P. vulgaris (2.9 kg) were placed in methanol at room temperature for 7 days. The resultant extract was then evaporated to dryness. The MeOH extract (54.0 g) was suspended in water and sequentially partitioned with methylene chloride (MC, 24.0 g). The MC-soluble fraction was subjected to silica gel vacuum liquid chromatography, and eluted with a stepwise gradient of MC/EtOAc/MeOH [10:0:0, 9:1:0, 4:1:0, 7:3:0, 1:1:0, 0:10:0, 0:9:1, 0:0:10 (each 3 L)] to give 6 fractions (Fr. 1 ~ 6). The inhibitory effect of Fr. 2 (6.3 g) and Fr. 5 (5.9 g) on histamine release was greater than that of other fractions. Fr. 2 was further divided into compound 1 (46.0 mg) and 9 sub-fractions (SFr. 2-2 to 2-10) by silica gel column chromatography (CC) with a mixture of MC/EtOAc (100:0 to 93:7). SFr. 2-5 was purified using HPLC with a gradient of MeOH:H 2 O (7:3→10:0) to yield compound 5 (63.0 mg). SFr. 2-6 and SFr. 2-7 were recrystallized from MeOH to obtain compounds 13 (38.0 mg) and 14 (35.8 mg). Fr. 5 was subjected to chromatography on RP-18 gel to yield compound 2 (880.0 mg) and 10 sub-fractions (SFr. 5-1 to SFr. 5-10) according to their TLC pattern. SFr. 5-3 (180.0 mg) was subjected to CC over silica gel by using a gradient of MC/acetone (10:0→0:10) to yield 12 minor sub-fractions (MSFrs). MSFr. 5-3-3 was purified using HPLC with a gradient of MeOH:H 2 O (7:3→10:0) to obtain compound 12 (1.0 mg). SFr. 5-4 (2.4 g) was loaded on a silica gel column and eluted with a gradient of MC/acetone (10:0 to 0:10) to yield 11 minor sub-fractions. MSFr. 5-4-3 (73.1 mg) was purified using HPLC with a gradient of MeOH:H 2 O (85:15→95:5, 6 mL/min), resulting in the isolation of compounds 6 (8.9 mg) and 7 (5.3 mg). Purification of MSFr. 5-4-5 (35.5 mg) using HPLC (MeOH-H 2 O, 83:17→9:1) yielded compound 8 (10.1 mg). MSFr. 5-4-6 (38.1 mg) was purified using HPLC with a gradient of MeOH:H 2 O (7:3→10:0) to yield compound 9 (11.0 mg). MSFr. 5-4-7 (108.7 mg) was also purified using HPLC with a gradient of MeOH:H 2 O (7:3→9:1) to yield compound 10 (11.8 mg). Compound 11 (21.0 mg) was isolated using HPLC with a gradient of MeOH: H 2 O (3:2→10:0) from MSFr. 5-4-10 (304.9 mg). Compounds 3 (64.7 mg) and 4 (39.9 mg) were isolated using HPLC with a gradient of MeOH:H 2 O (4:1→10:0) from SFr. 5-5 (240.3 mg).
Histamine assay:
The histamine content was measured by the o-phthaldialdehyde spectrofluorometric procedure as previously described [4a] .
Real-time polymerase chain reaction (PCR):
Quantitative real-time PCR was carried out using the Thermal Cycler Dice TP850 (Takarabio Inc., Shiga, Japan) according to the manufacturer's protocol. Total RNA was isolated from ear tissues of each group. The conditions for PCR were similar to those previously described [4b].
Statistical analysis: Statistical analyses were performed using SAS statistical software (SAS Institute, Cary, NC, USA). Treatment effects were analyzed using ANOVA followed by Dunnett's multiple range tests. Significance was set at P < 0.05.
